SCHEMBL13836282

SCHEMBL13836282

CCc1cc(C(F)(C(F)(F)F)C(F)(F)C(F)(F)F)cc(C)c1NC(=O)c1cccc(NC(=O)c2ccc(F)cc2Cl)c1OC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 2/20 0.42
LMNA P02545 2/20 0.42
RAB9A P51151 2/20 0.42
KDM4E B2RXH2 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
AVPR2 P30518 2/20 0.40
OXTR P30559 2/20 0.40
AVPR1A P37288 2/20 0.40
PTGES O14684 2/20 0.40
MAPT P10636 2/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PYGL P06737 5/20 0.38
PPARG P37231 1/20 0.36
GAA P10253 2/20 0.36
TAS1R3 Q7RTX0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13835559 0.89 HTR1F (0.45) ALDH1A1SMN1; SMN2NPC1LMNARAB9A
SCHEMBL13835132 0.89 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2NPC1LMNARAB9A
SCHEMBL14850246 0.88 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2NPC1LMNARAB9A
SCHEMBL13968275 0.86 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2NPC1LMNARAB9A
SCHEMBL13836482 0.85 KDM4E (0.39) ALDH1A1SMN1; SMN2NPC1LMNARAB9A
SCHEMBL15073412 0.83 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2NPC1LMNARAB9A
SCHEMBL299503 0.83 GPR6 (0.39) ALDH1A1SMN1; SMN2NPC1LMNARAB9A
SCHEMBL298947 0.82 KMT2A (0.45) SMN1; SMN2LMNARAB9ANPSR1MAPT
SCHEMBL13968284 0.82 SMN1; SMN2 (0.43) ALDH1A1SMN1; SMN2NPC1LMNARAB9A
SCHEMBL297521 0.82 RXFP1 (0.45) ALDH1A1SMN1; SMN2NPC1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3339286-A1 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2018-06-27 EP disclosed
EP-2427426-B1 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2018-02-07 EP disclosed
WO-2013092942-A1 USE OF AMINOBENZAMIDE DERIVATIVES FOR CONTROLLING ANIMAL PARASITES SYNGENTA PARTICIPATIONS AG (CH) 2013-06-27 WO disclosed
US-20120295907-A1 INSECTICIDAL COMPOUNDS SYNGENTA CROP PROTECTION, LLC (US) 2012-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120295907-A1 INSECTICIDAL COMPOUNDS ACHE, AADAC, BCHE ALDH1A1 331/4885SMN1; SMN2 1116/4885NPC1 918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.